The University of Chicago Header Logo

Pankti Reid

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Rheumatology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Singh AG, Hughes GC, Pioro M, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk. JAMA Netw Open. 2024 Nov 04; 7(11):e2446336. PMID: 39565623; PMCID: PMC11579790.
      Citations:    Fields:    Translation:Humans
    2. Thompson JA, Schneider BJ, Brahmer J, Zaid MA, Achufusi A, Armand P, Berkenstock MK, Bermas B, Braaten T, Budde LE, Chokshi S, Crees ZD, Davies M, Deng C, Gesthalter Y, Jain M, Jain P, Jallouk A, Kaffenberger BH, Khalil M, Lechner MG, Li T, Marr A, McGettigan S, McPherson J, Medina T, Mohindra NA, Olszanski AJ, Oluwole O, Patel SP, Prosek J, Reddy S, Reid P, Ryan J, Ryder M, Salman H, Santomasso B, Shofer S, Sosman JA, Wang Y, Zaha VG, Zucker S, Lyons M, Awotiwon A, Hang L. NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw. 2024 Nov; 22(9):582-592. PMID: 39536465.
      Citations: 1     Fields:    Translation:Humans
    3. Syed S, Hines J, Baccile R, Rouhani S, Reid P. Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study. Cancers (Basel). 2024 May 16; 16(10). PMID: 38791970; PMCID: PMC11119129.
      Citations:    
    4. Kim S, Chen N, Reid P. Current and future advances in practice: aromatase inhibitor-induced arthralgia. Rheumatol Adv Pract. 2024; 8(2):rkae024. PMID: 38601139; PMCID: PMC11003819.
      Citations:    
    5. Gómez-Puerta JA, Gente K, Katsumoto TR, Leipe J, Reid P, van Binsbergen WH, Suarez-Almazor ME. Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis. Rheum Dis Clin North Am. 2024 05; 50(2):161-179. PMID: 38670719.
      Citations: 1     Fields:    Translation:Humans
    6. Vitzthum von Eckstaedt H, Singh A, Reid P, Trotter K. Immune Checkpoint Inhibitors and Lupus Erythematosus. Pharmaceuticals (Basel). 2024 Feb 15; 17(2). PMID: 38399467; PMCID: PMC10892070.
      Citations:    
    7. Klionsky Y, Simon Meara A, Reid P. Immunotherapy Toxicity Management in Clinical Practice: Building the Clinical Infrastructure for Immune-related Adverse Event Evaluation and Care. Rheum Dis Clin North Am. 2024 05; 50(2):229-239. PMID: 38670722.
      Citations:    Fields:    Translation:Humans
    8. Reid P, Sandigursky S, Song J, Lopez-Olivo MA, Safa H, Cytryn S, Efuni E, Buni M, Pavlick A, Krogsgaard M, Abu-Shawer O, Altan M, Weber JS, Rahma OE, Suarez-Almazor ME, Diab A, Abdel-Wahab N. Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology. 2023; 12(1):2261264. PMID: 38126033; PMCID: PMC10732692.
      Citations: 3     Fields:    Translation:Humans
    9. Tokareva K, Reid P, Yang V, Liew D, Peterson AC, Baraff A, Giles J, Singh N. JAK inhibitors and black box warnings: what is the future for JAK inhibitors? Expert Rev Clin Immunol. 2023 Jul-Dec; 19(11):1385-1397. PMID: 37596779; PMCID: PMC10615860.
      Citations: 5     Fields:    Translation:Humans
    10. Yang V, Kragstrup TW, McMaster C, Reid P, Singh N, Haysen SR, Robinson PC, Liew DFL. Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071. PMID: 37490213; PMCID: PMC10632271.
      Citations: 8     Fields:    Translation:Humans
    11. Stahlbaum D, Jablonski R, Strek ME, Bestvina CM, Polley MY, Reid P. Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis. Respir Med. 2023 Oct; 217:107330. PMID: 37385460.
      Citations: 1     Fields:    
    12. Ghosh N, Reid P, Aude CA, Kirschman J, Goodman S, Bykerk VP, Lakhanpal A, Rajesh D, Chan KK, Robinson WH, Bass AR. Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD Open. 2023 06; 9(2). PMID: 37355249; PMCID: PMC10314674.
      Citations: 1     Translation:Humans
    13. Mathias K, Rouhani S, Olson D, Bass AR, Gajewski TF, Reid P. Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events. Oncologist. 2023 05 08; 28(5):440-448. PMID: 36595378; PMCID: PMC10166164.
      Citations: 4     Fields:    Translation:Humans
    14. Reid P, Sparks JA, Bass AR. Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events. JAMA Oncol. 2023 05 01; 9(5):723-724. PMID: 36892846.
      Citations: 3     Fields:    Translation:Humans
    15. Wesevich A, He G, Tomczyk G, Reid P. Role-Specific Curricular Needs for Identification and Management of Immune-Related Adverse Events. J Cancer Educ. 2023 10; 38(5):1486-1492. PMID: 37022615; PMCID: PMC10078044.
      Citations: 1     Fields:    Translation:Humans
    16. Bass AR, Abdel-Wahab N, Reid PD, Sparks JA, Calabrese C, Jannat-Khah DP, Ghosh N, Rajesh D, Aude CA, Gedmintas L, MacFarlane L, Arabelovic S, Falohun A, Mushtaq K, Haj FA, Diab A, Shah AA, Bingham CO, Chan KK, Cappelli LC. Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Ann Rheum Dis. 2023 07; 82(7):920-926. PMID: 37019614; PMCID: PMC10330686.
      Citations: 16     Fields:    Translation:Humans
    17. Macklin M, Yadav S, Jan R, Reid P. Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics. Pharmaceuticals (Basel). 2023 Feb 08; 16(2). PMID: 37259404; PMCID: PMC9962184.
      Citations: 6     
    18. Reid P, Cappelli LC. Treatment of rheumatic adverse events of cancer immunotherapy. Best Pract Res Clin Rheumatol. 2022 12; 36(4):101805. PMID: 36539321; PMCID: PMC10198805.
      Citations: 10     Fields:    Translation:Humans
    19. Saygin D, Ghosh N, Reid P. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. J Clin Rheumatol. 2022 Oct 01; 28(7):367-373. PMID: 35696731.
      Citations: 5     Fields:    Translation:Humans
    20. Reid P, Guler SA. Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung Disease. Ann Am Thorac Soc. 2021 12; 18(12):1953-1954. PMID: 34851244; PMCID: PMC8641812.
      Citations: 3     Fields:    Translation:Humans
    21. Reid P, Liew DF, Akruwala R, Bass AR, Chan KK. Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. J Immunother Cancer. 2021 09; 9(9). PMID: 34526389; PMCID: PMC8444247.
      Citations: 7     Fields:    Translation:Humans
    22. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Benbenishty JS, Berry LR, Broman N, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Pizov R, Postma S, Rajasuriar R, Ramanan AV, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Tsai LW, van Hoogstraten H, van Meerten T, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC, Baron G, Cavalcanti AB, Mariette X, Perez-Molina JA, Porcher R, Ravaud P, Torre-Cisneros J, Veiga VC. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA. 2021 08 10; 326(6):499-518. PMID: 34228774; PMCID: PMC8261689.
      Citations: 350     Fields:    Translation:Humans
    23. Wu M, Bennett JA, Reid P, Fleming GF, Kurnit KC. Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab. Gynecol Oncol Rep. 2021 Aug; 37:100837. PMID: 34368414; PMCID: PMC8326349.
      Citations: 4     
    24. Cifu AS, Bass AR, Reid PD. Immune Checkpoint Inhibitor Therapy Toxicities-Reply. JAMA. 2021 07 06; 326(1):87-88. PMID: 34228068.
      Citations: 1     Fields:    Translation:Humans
    25. Strohbehn GW, Parker WF, Reid PD, Gellad WF. Socially optimal pandemic drug dosing. Lancet Glob Health. 2021 08; 9(8):e1049-e1050. PMID: 34139194; PMCID: PMC8203182.
      Citations: 5     Fields:    Translation:Humans
    26. Hines J, Daily E, Pham AK, Shea CR, Nadeem U, Husain AN, Stadler WM, Reid P. Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report. J Med Case Rep. 2021 Mar 19; 15(1):124. PMID: 33736690; PMCID: PMC7977267.
      Citations: 2     Fields:    Translation:Humans
    27. Reid PD, Cifu AS, Bass AR. Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy. JAMA. 2021 Feb 02; 325(5):482-483. PMID: 33528524.
      Citations: 18     Fields:    Translation:Humans
    28. Reid P, Danahey K, Lopez Velazquez M, Ratain MJ, O'Donnell PH. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis. Clin Exp Rheumatol. 2021 Nov-Dec; 39(6):1385-1393. PMID: 33506753.
      Citations: 1     Fields:    Translation:Humans
    29. Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol AK, Weiss A, Danahey K, Karrison TG, Edens CC, Bauer Ventura I, Pettit NN, Patel BK, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PD. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696. PMID: 33210302; PMCID: PMC7753375.
      Citations: 33     Fields:    Translation:HumansCellsCTClinical Trials
    30. Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol A, Weiss A, Danahey K, Karrison TG, Edens CC, Ventura IB, Pettit NN, Patel B, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PD. COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. medRxiv. 2020 Jul 26. PMID: 32743594; PMCID: PMC7386518.
      Citations:    
    31. Kurnit KC, Reid P, Moroney JW, Fleming GF. Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations. Gynecol Oncol. 2020 09; 158(3):531-537. PMID: 32641238.
      Citations: 4     Fields:    Translation:Humans
    32. Strohbehn GW, Reid PD, Ratain MJ. Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19. Clin Pharmacol Ther. 2020 09; 108(3):425-427. PMID: 32488861; PMCID: PMC7300962.
      Citations: 2     Fields:    Translation:Humans
    33. Reid P, Miloslavsky EM, Dua A. Teacher training for rheumatology fellows: a national needs assessment of fellows and program directors. Clin Rheumatol. 2020 Mar; 39(3):673-680. PMID: 31832802.
      Citations: 1     Fields:    Translation:Humans
    34. Gallan AJ, Alexander E, Reid P, Kutuby F, Chang A, Henriksen KJ. Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors. Am J Kidney Dis. 2019 12; 74(6):853-856. PMID: 31204194.
      Citations: 32     Fields:    Translation:Humans
    35. Yuen C, Reid P, Zhang Z, Soliven B, Luke JJ, Rezania K. Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study. J Immunother. 2019 04; 42(3):94-96. PMID: 30614917.
      Citations: 3     Fields:    Translation:Humans
    36. Ventura I, Reid P, Jan R. Approach to Patients with Suspected Rheumatic Disease. Prim Care. 2018 Jun; 45(2):169-180. PMID: 29759118.
      Citations: 6     Fields:    Translation:Humans
    37. Vaskova M, Bentley AM, Marshall S, Reid P, Thummel CS, Andres AJ. Genetic analysis of the Drosophila 63F early puff. Characterization of mutations in E63-1 and maggie, a putative Tom22. Genetics. 2000 Sep; 156(1):229-44. PMID: 10978288; PMCID: PMC1461229.
      Citations: 6     Fields:    Translation:AnimalsCells
    Reid's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (136)
    Explore
    _
    Co-Authors (29)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _